|
|
|
|
iCo Therapeutics Announces Leadership Changes
|
Vancouver, BC, March 11, 2020--iCo Therapeutics Inc. (TSXV: ICO) announced that Andrew Rae, MBA, has resigned from his roles as both President & CEO and Director. Mr. Rae has agreed to assist management, through to the end of the fiscal quarter, to ensure a smooth and orderly transition.
|
|
|
|
|
|
|